Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 830837, 8 pages
http://dx.doi.org/10.1155/2013/830837
Review Article

Therapies for Neovascular Age-Related Macular Degeneration: Current Approaches and Pharmacologic Agents in Development

1Retinal Imaging Research and Reading Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2Ocular Imaging Research and Reading Center, Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, 3902 Leavenworth Street, Omaha, NE, USA
3Department of Ophthalmology, Retina Service, University of São Paulo Medical School, 05403-000 São Paulo, SP, Brazil

Received 12 August 2013; Accepted 30 September 2013

Academic Editor: Daniel Petrovič

Copyright © 2013 Mostafa Hanout et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [35 citations]

The following is the list of published articles that have cited the current article.

  • Hua Ren, Chao Zhu, Zhaohui Li, Wei Yang, and E. Song, “Emodin-Loaded Magnesium Silicate Hollow Nanocarriers for Anti-Angiogenesis Treatment through Inhibiting VEGF,” International Journal of Molecular Sciences, vol. 15, no. 9, pp. 16936–16948, 2014. View at Publisher · View at Google Scholar
  • Volkan Okur, Ozan Cetin, Ebru Cetin, Emre Tepeli, Yunus Bulgu, and Cem Yildirim, “ HIF1A as a major vascular endothelial growth factor regulator: do its polymorphisms have an association with age-related macular degeneration? ,” Clinical & Experimental Ophthalmology, 2014. View at Publisher · View at Google Scholar
  • Giovanni Casini, Massimo Dal Monte, Irene Fornaciari, Luca Filippi, and Paola Bagnoli, “The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases,” Progress in Retinal and Eye Research, 2014. View at Publisher · View at Google Scholar
  • Alex W. Hewitt, and Kathryn C. Davidson, “Stem Cell Strategies for Diseases of the Outer Retina,” Regenerative Biology of the Eye, pp. 145–159, 2014. View at Publisher · View at Google Scholar
  • Karl G. Csaky, Pravin U. Dugel, Amy J. Pierce, Michael A. Fries, Deborah S. Kelly, Ronald P. Danis, John I. Wurzelmann, Chun-Fang Xu, Mohammad Hossain, and Trupti Trivedi, “Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration,” Ophthalmology, 2014. View at Publisher · View at Google Scholar
  • Rosa M. Coco, M. Rosa Sanabria, Melissa Castrejon, M. Isabel Lopez-Galvez, Laura Monje-Fernandez, Marta Fernandez-Munoz, Alejandro Anton, Lourdes de Juan-Marcos, Sonia Villaron-Alvarez, and Itziar Fernandez, “Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain,” Bmc Ophthalmology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Christoph Mitsch, Stefan Sabutsch, Ursula Schmidt-Erfurth, Matthias Bolz, Stefan Sacu, Clemens Vass, Christoph Scholda, and Patrick Huber, “OphthalNet vienna: Constructive quality assurance and resource optimization in ophthalmology,” Studies in Health Technology and Informatics, vol. 198, pp. 156–163, 2014. View at Publisher · View at Google Scholar
  • Martina Santarelli, Laura Diplotti, Francesco Samassa, Daniele Veritti, Baruch D Kuppermann, and Paolo Lanzetta, “Advances in pharmacotherapy for wet age-related macular degeneration,” Expert Opinion on Pharmacotherapy, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Aniruddha Agarwal, William R. Rhoades, Mostafa Hanout, Mohamed Kamel Soliman, Salman Sarwar, Mohammad Ali Sadiq, Yasir Jamal Sepah, Diana V. Do, and Quan Dong Nguyen, “Management of neovascular age-related macular degeneration: Current state-of-the-art care for optimizing visual outcomes and therapies in development,” Clinical Ophthalmology, vol. 9, pp. 1001–1015, 2015. View at Publisher · View at Google Scholar
  • Hossein Nazari, Lily Zhang, Danhong Zhu, Gerald J. Chader, Paulo Falabella, Francisco Stefanini, Teisha Rawland, Dennis O. Clegg, Amir H. Kashani, David R. Hinton, and Mark S. Humayun, “Stem cell based therapies for age-related macular degeneration: the promises and the challenges,” Progress in Retinal and Eye Research, 2015. View at Publisher · View at Google Scholar
  • Christopher M. C. Mattice, and Maria C. DeRosa, “Status and Prospects of Aptamers as Drug Components,” BioDrugs, 2015. View at Publisher · View at Google Scholar
  • Felix Grassmann, Sascha Fauser, and Bernhard H.F. Weber, “The genetics of age-related macular degeneration (AMD) – novel targets for designing treatment options?,” European Journal of Pharmaceutics and Biopharmaceutics, 2015. View at Publisher · View at Google Scholar
  • Gallego-Pinazo, and Zapata, “New perspectives in the approach to age-related macular degeneration,” Archivos de la Sociedad Espanola de Oftalmologia, vol. 90, no. 1, pp. 11–14, 2015. View at Publisher · View at Google Scholar
  • Chiara B. M. Platania, Luisa Di Paola, Gian M. Leggio, Giovanni L. Romano, Filippo Drago, Salvatore Salomone, and Claudio Bucolo, “Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach,” Frontiers in Pharmacology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Chiara B. M. Platania, Luisa Di Paola, Gian M. Leggio, Giovanni L. Romano, Filippo Drago, Salvatore Salomone, and Claudio Bucolo, “Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach,” Frontiers In Pharmacology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Kevin Lai, and Gennady Landa, “Current choice of treatments for neovascular AMD,” Expert Review of Clinical Pharmacology, vol. 8, no. 1, pp. 135–140, 2015. View at Publisher · View at Google Scholar
  • Chiara B.M. Platania, Luisa Di Paola, Gian M. Leggio, Giovanni L. Romano, Filippo Drago, Salvatore Salomone, and Claudio Bucolo, “Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: A computational approach,” Frontiers in Pharmacology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Adnan Mallick, and Ronni M. Lieberman, “Recent Innovations in Stem Cell Therapy for Retinal Disease,” Advances in Ophthalmology and Optometry, vol. 1, no. 1, pp. 85–109, 2016. View at Publisher · View at Google Scholar
  • Sally Ingham, Mohammad Ali Sadiq, and Diana V. Do, “Choroidal Neovascularization,” Encyclopedia of Ophthalmology, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Ugur Acar, Damla Erginturk Acar, Ferda Alpaslan Pinarli, Muhammed N Demir, Emrullah Beyazyildiz, Ozdemir Ozdemir, Duygu Gulmez Sevim, Meral Tiryaki, and Gungor Sobaci, “Effects of commonly used intravitreal anti-vascular endothelial growth factor drugs on mesenchymal stem cells derived from the limbus and ciliary body,” Clinical & Experimental Ophthalmology, vol. 44, no. 7, pp. 587–596, 2016. View at Publisher · View at Google Scholar
  • Radwan S. Ajlan, Paolo S. Silva, and Jennifer K. Sun, “Vascular Endothelial Growth Factor and Diabetic Retinal Disease,” Seminars in Ophthalmology, vol. 31, no. 1-2, pp. 40–48, 2016. View at Publisher · View at Google Scholar
  • Chris Greene, and Matthew Campbell, “Tight junction modulation of the blood brain barrier: CNS delivery of small molecules,” Tissue Barriers, pp. 00–00, 2016. View at Publisher · View at Google Scholar
  • Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma, C. George Priya Doss, and Sang-Soo Lee, “Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine,” Molecular Therapy - Nucleic Acids, vol. 8, pp. 132–143, 2017. View at Publisher · View at Google Scholar
  • Adnan Mallick, Peter Belin, and Ronni M. Lieberman, “Recent Innovations in Gene Therapy for Retinal Disease,” Advances in Ophthalmology and Optometry, vol. 2, no. 1, pp. 197–224, 2017. View at Publisher · View at Google Scholar
  • Lucia Gonzalez-Buendia, Santiago Delgado-Tirado, M. Rosa Sanabria, Itziar Fernandez, and Rosa M. Coco, “Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab,” BMC Ophthalmology, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Halesha D Basavarajappa, Christian M Briggs, Kamna Gupta, Buyun Tang, Mehdi Shadmand, Maria B Grant, Michael E Boulton, Seung-Yong Seo, Timothy W Corson, Rania S Sulaiman, Xiaoping Qi, Trupti Shetty, Sardar Sheik Pran Babu, Kamakshi L Sishtla, Bit Lee, Judith Quigley, and Sameerah Alkhairy, “Ferrochelatase is a therapeutic target for ocular neovascularization,” EMBO Molecular Medicine, vol. 9, no. 6, pp. 786–801, 2017. View at Publisher · View at Google Scholar
  • Gabriele Thumann, Nina Harmening, Cécile Prat-Souteyrand, Corinne Marie, Marie Pastor, Attila Sebe, Csaba Miskey, Laurence D. Hurst, Sabine Diarra, Martina Kropp, Peter Walter, Daniel Scherman, Zoltán Ivics, Zsuzsanna Izsvák, and Sandra Johnen, “Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids,” Molecular Therapy - Nucleic Acids, vol. 6, pp. 302–314, 2017. View at Publisher · View at Google Scholar
  • Khalil Ghasemi Falavarjani, and Srinivas R. Sadda, “Hot topics in pharmacotherapy for neovascular age-related macular degeneration,” Current Pharmaceutical Design, vol. 23, no. 4, pp. 535–541, 2017. View at Publisher · View at Google Scholar
  • Taeyoung Koo, Sung Wook Park, Dong Hyun Jo, Daesik Kim, Jin Hyoung Kim, Hee-Yeon Cho, Jeungeun Kim, Jeong Hun Kim, and Jin-Soo Kim, “CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration,” Nature Communications, vol. 9, no. 1, 2018. View at Publisher · View at Google Scholar
  • Sally Ingham, Mohammad Ali Sadiq, and Diana V. Do, “Choroidal Neovascularization,” Encyclopedia of Ophthalmology, pp. 404–411, 2018. View at Publisher · View at Google Scholar
  • Tanya Camacho-Villegas, María Mata-González, Walter García-Ubbelohd, Linda Núñez-García, Carolina Elosua, Jorge Paniagua-Solis, and Alexei Licea-Navarro, “Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization,” Marine Drugs, vol. 16, no. 4, pp. 113, 2018. View at Publisher · View at Google Scholar
  • Michael T. Bowser, and Sean K. Dembowski, “Microfluidic methods for aptamer selection and characterization,” Analyst, vol. 143, no. 1, pp. 21–32, 2018. View at Publisher · View at Google Scholar
  • Jing Cao, Rong Yang, Taylor E. Smith, Stephanie Evans, Gary W. McCollum, Steven C. Pomerantz, Theodore Petley, Ian R. Harris, and John S. Penn, “Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization,” Molecular Therapy - Methods & Clinical Development, vol. 14, pp. 37–46, 2019. View at Publisher · View at Google Scholar
  • Chi-Hsiu Liu, Zhongxiao Wang, Shuo Huang, Ye Sun, and Jing Chen, “MicroRNA-145 Regulates Pathological Retinal Angiogenesis by Suppression of TMOD3,” Molecular Therapy - Nucleic Acids, vol. 16, pp. 335–347, 2019. View at Publisher · View at Google Scholar
  • Theodoros Empeslidis, Matthew Storey, Theodoros Giannopoulos, Vassileios Konidaris, Paris G. Tranos, Evangelia S. Panagiotou, Irini C. Voudouragkaki, and Anastasios G. Konstas, “How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview,” Advances in Therapy, 2019. View at Publisher · View at Google Scholar